MHRA Blog - Innovation, Quality & Transparency – a Compliance Team 1 Perspective

30th August 2022

MHRA Blog Post

There has been much discussion of late between regulators and industry on how we can ensure that patients and the public get new medicines as quickly as possible - all the way from development to regulatory approval - while still ensuring they are safe, effective and of the required quality.

Read More

Back to News Archive